Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


GREY:VIVXF - Post by User

Avivagen Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by drilltip1on Feb 18, 2012 2:00pm
151 Views
Post# 19554170

RE: Market disconnect here!

RE: Market disconnect here!

Yes it appears that's what's happening. Take a little time to get it all implimented is my guess. I'm trying to figure out what the next NR might be, news on actual orders of the prducts, can the current facility handle said orders, news on what locations will be carrying the products and will they need more money or will sales revenue come to the rescue in time. Market reaction is a little odd but I do agree sometimes it takes a few days to pick up steam I have also seen this happen before.

I bought in because I like it but I will admit it will be a news driven story in my opinion so we have to just wait for time to take care of it all. Still would like some info on the next quarterly or annual, it has to be very soon and I can't wait to see if the revs continued on the growth rate that it had in the previous quarterly report, went to just under 90,000 from 38 I think if I remember right. Now I know going forward these numbers will be much larger but I still would like to know how the company did with the products they did have in the last reporting period.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities